Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers
Faiena I, Kim S, Farber N, Kwon Y, Shinder B, Patel N, Salmasi A, Jang T, Singer E, Kim W, Kim I. Predicting clinically significant prostate cancer based on pre-operative patient profile and serum biomarkers. Oncotarget 2017, 5: 109783-109790. PMID: 29312648, PMCID: PMC5752561, DOI: 10.18632/oncotarget.21297.Peer-Reviewed Original ResearchClinical Gleason scoreBody mass indexProstate-specific antigenSignificant prostate cancerProstate acid phosphatasePreoperative prostate-specific antigenGleason scoreProstate cancerSerum biomarkersProstate weightParathyroid hormoneTotal prostate-specific antigenBias-corrected areaMultiple preoperative factorsPreoperative factorsOncologic characteristicsPatient characteristicsProstatectomy databaseMass indexRisk stratificationClinical stageUnivariate analysisPatient profilesHormone profilesMultivariate analysis